Login to Your Account



BioWorld Perspectives: Commentary

Extra! Extra! Leukemia Therapy Purposely Misses Holy Grail!

By Anette Breindl


Friday, August 12, 2011
This week's report of remissions in three advanced leukemia patients after immunotherapy has generated quite a lot of excitement in the media – which, in turn, has led to some backlash amongst the twitterati and in the blogosphere, noting that two complete remissions plus a partial one don't make a blockbuster. Or anything, really, that will be broadly useful within the next few years.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription